about
Effects of 1,25(OH)₂D₃ on Cancer Cells and Potential Applications in Combination with Established and Putative Anti-Cancer Agents.Vitamin D deficiency and cardiovascular disease: potential mechanisms and novel perspectives.Vitamin D receptor gene polymorphisms (TaqI and ApaI) in relation to 25-hydroxyvitamin D levels and coronary artery disease incidence.Association of suboptimal 25-hydroxyvitamin D levels with knee osteoarthritis incidence in post-menopausal Egyptian women.Effect of polymorphisms in the NADSYN1/DHCR7 locus (rs12785878 and rs1790349) on plasma 25-hydroxyvitamin D levels and coronary artery disease incidence.Insights on vitamin D's role in cardiovascular disease: investigating the association of 25-hydroxyvitamin D with the dimethylated arginines.A multi-target caffeine derived rhodium(i) N-heterocyclic carbene complex: evaluation of the mechanism of action.Vitamin D as a Novel Regulator of Tumor Metabolism: Insights on Potential Mechanisms and Implications for Anti-Cancer Therapy.Differences in p53 status significantly influence the cellular response and cell survival to 1,25-dihydroxyvitamin D3-metformin cotreatment in colorectal cancer cells.Alkynyl gold(I) phosphane complexes: Evaluation of structure-activity-relationships for the phosphane ligands, effects on key signaling proteins and preliminary in-vivo studies with a nanoformulated complex.Expression of TXNIP in Cancer Cells and Regulation by 1,25(OH)₂D₃: Is It Really the Vitamin D₃ Upregulated Protein?Genetic variation in vitamin D receptor gene (Fok1:rs2228570) is associated with risk of coronary artery disease.Triangular relationship between single nucleotide polymorphisms in the CYP2R1 gene (rs10741657 and rs12794714), 25-hydroxyvitamin d levels, and coronary artery disease incidence.Interplay of vitamin D and nitric oxide in post-menopausal knee osteoarthritisActivation of pro-survival metabolic networks by 1,25(OH)2D3 does not hamper the sensitivity of breast cancer cells to chemotherapeutics
P50
Q37628495-475DD1A1-CDEB-4F4B-8221-2B604CED733FQ38183252-1BE53A5A-0347-4B98-96E7-99AEF1B78D3FQ38858496-5A5487DA-AC32-4369-B73E-C6B6D6944659Q38858500-C56A2316-A037-4617-A68E-B6C4C67DA3F7Q43548943-6541592C-C60A-4744-8464-8E7A6982B48DQ43685563-96A0A8A6-3DE8-4246-83C6-3D361841AB10Q46528613-DDDBA9E2-73B5-426D-AA69-C8901C0FC2A2Q46921354-AE7FB9E3-8276-4E4D-8BBD-6333BAC06134Q47861796-B8C8A26F-23E4-44EC-9809-2555C9A2CB6DQ50882995-FBA17EB9-195B-4C88-BC25-D71E717879B4Q51740717-0AD8BFE0-16B4-4956-BA37-3FCA131C0708Q53780686-E7D32D21-3A29-448F-9F99-A4A6D409986FQ54488534-A4EA2962-0C6B-4F04-A0B2-6CB873E42940Q61414542-222163F6-0CCE-49C5-985A-F8170DE60A45Q91290420-6F85118E-4942-4DBD-8A9B-5415D1C4D025
P50
description
researcher ORCID ID = 0000-0002-8760-6376
@en
wetenschapper
@nl
name
Mohamed A Abu El Maaty
@ast
Mohamed A Abu El Maaty
@en
Mohamed A Abu El Maaty
@es
Mohamed A Abu El Maaty
@nl
type
label
Mohamed A Abu El Maaty
@ast
Mohamed A Abu El Maaty
@en
Mohamed A Abu El Maaty
@es
Mohamed A Abu El Maaty
@nl
prefLabel
Mohamed A Abu El Maaty
@ast
Mohamed A Abu El Maaty
@en
Mohamed A Abu El Maaty
@es
Mohamed A Abu El Maaty
@nl
P106
P1153
55443302000
P214
1446148705739937080007
P31
P496
0000-0002-8760-6376
P7859
viaf-1446148705739937080007